AbGn-5

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAbGn-5
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, T-CellLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltrubio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltrubio Inc
Active IndicationsN/A
Inactive IndicationsLymphoma, T-CellLeukemia

Other Information

ATC CodeN/A
Related LinksN/A